Mental disorders in ecstasy users: a prospective-longitudinal investigation (Q33961393)

30 July 2017

title

Mental disorders in ecstasy users: a prospective-longitudinal investigation (English)

1 reference

30 July 2017

Kirsten von Sydow

0 references

Hans Wittchen

1 reference

30 July 2017

Roselind Lieb

1 reference

30 July 2017

Christian G Schuetz

1 reference

30 July 2017

Hildegard Pfister

series ordinal

1 reference

30 July 2017

publication date

1 October 2002

1 reference

Drug and Alcohol Dependence

30 July 2017

published in

1 reference

30 July 2017

1 reference

30 July 2017

1 reference

30 July 2017

page(s)

195-207

1 reference

Designer drugs--the "whats" and the "whys".

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2802%2900190-4

7 January 2021

Amphetamine designer drugs - an overview and epidemiology

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2802%2900190-4

7 January 2021

Covariates of cannabis use progression in a representative population sample of adolescents: a prospective examination of vulnerability and risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2802%2900190-4

7 January 2021

Ecstasy (MDMA) dependence.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2802%2900190-4

7 January 2021

Chronic 3,4-methylenedioxymethamphetamine (MDMA) use: effects on mood and neuropsychological function?

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2802%2900190-4

7 January 2021

Structure, Content and Reliability of the Munich-Composite International Diagnostic Interview (M-CIDI) Substance Use Sections

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2802%2900190-4

7 January 2021

The Early Developmental Stages of Psychopathology Study (EDSP): A Methodological Update

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2802%2900190-4

7 January 2021

Phenomenology and sequelae of 3,4-methylenedioxymethamphetamine use

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2802%2900190-4

7 January 2021

Serotonin neurotoxicity after (+/-)3,4-methylenedioxymethamphetamine (MDMA; "Ecstasy"): a controlled study in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2802%2900190-4

7 January 2021

(+/-)3,4-Methylenedioxymethamphetamine ('Ecstasy')-induced serotonin neurotoxicity: clinical studies

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2802%2900190-4

7 January 2021

Recreational use of "ecstasy" (MDMA) is associated with elevated impulsivity

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2802%2900190-4

7 January 2021

Cognitive performance in recreational users of MDMA of 'ecstasy': evidence for memory deficits

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2802%2900190-4

7 January 2021

Ecstasy and new patterns of drug use: a normal population study.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2802%2900190-4

7 January 2021

Prevalence of use, abuse and dependence of illicit drugs among adolescents and young adults in a community sample

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2802%2900190-4

7 January 2021

Substance use, abuse and dependence in Germany. A review of selected epidemiological data.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2802%2900190-4

7 January 2021

Patterns of cannabis use, abuse and dependence over time: incidence, progression and stability in a sample of 1228 adolescents.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2802%2900190-4

7 January 2021

Hallucinogenic amphetamine selectively destroys brain serotonin nerve terminals

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2802%2900190-4

7 January 2021

(+/-)3,4-Methylenedioxymethamphetamine ('Ecstasy')-induced serotonin neurotoxicity: studies in animals

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2802%2900190-4

7 January 2021

MDMA ('ecstasy') consumption in the context of polydrug abuse: a report on 150 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2802%2900190-4

7 January 2021

Is the use of ecstasy and hallucinogens increasing? Results from a community study

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2802%2900190-4

7 January 2021

Analysis of illicit ecstasy tablets: implications for clinical management in the accident and emergency department

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2802%2900190-4

7 January 2021

Recreational MDMA use in Sydney: a profile of 'Ecstacy' users and their experiences with the drug

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2802%2900190-4

7 January 2021

[MDMA ("Ecstasy") use--an overview of psychiatric and medical sequelae]

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2802%2900190-4

7 January 2021

Ecstasy use in Australia: patterns of use and associated harm

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2802%2900190-4

7 January 2021

Psychological and cardiovascular effects and short-term sequelae of MDMA ("ecstasy") in MDMA-naïve healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2802%2900190-4

7 January 2021

Early developmental stages of psychopathology study (EDSP): objectives and design.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2802%2900190-4

7 January 2021

Prevalence of mental disorders and psychosocial impairments in adolescents and young adults

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2802%2900190-4

7 January 2021

Test-retest reliability of the computerized DSM-IV version of the Munich-Composite International Diagnostic Interview (M-CIDI).

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2802%2900190-4

7 January 2021

10.1016/S0376-8716(02)00190-4

Identifiers

DOI

1 reference

30 July 2017

1 reference